Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Surging global demand for stationary grid-scale energy storage represents Albemarle's most compelling growth catalyst.
Spot lithium carbonate prices in China falling below $12/kg LCE for two consecutive quarters.
Albemarle Corporation is rated Hold with a Fair value of $108.19 per share, representing 9.83% implied upside from the share price of $98.51 as of October 12, 2026.2
Albemarle Corporation is an established global leader in the production of battery-grade lithium compounds, bromine derivatives, and specialty performance chemicals. The company's premier asset base includes the world-class Salar de Atacama brine operations in Chile and a 49% stake in the Greenbushes hard-rock spodumene mine via the Talison joint venture in Australia. These structural resource advantages position Albemarle in the lowest cost quartile of global lithium extraction, enabling the business to remain operational cash positive through severe cyclical commodity downturns. In FY2025, Albemarle demonstrated this resilience by generating $1,282,267,000 in operating cash flow despite realized lithium market prices dropping precipitously from peak levels.5
Following a multi-year period of aggressive greenfield capital expansion, management has successfully enacted rigorous capital discipline. Capital expenditures decreased substantially to $589,801,000 in FY2025, dipping below annual depreciation and amortization. This capital rationalization converted free cash flow positive to $692,466,000, eliminating near-term balance sheet distress and insulating liquidity. In addition, the non-lithium Specialties segment serves as an essential cash flow anchor, generating $1,366,435,000 in FY2025 revenue and tracking full-year 2026 EBITDA guidance of $275,000,000 to $325,000,000.3456
The investment committee affirms a Hold rating. The synthesized house Fair value midpoint of $108.19 sits 29.3% below the present-value equivalent of the analyst consensus 12-month price target ($152.97 discounted at 10.20% cost of equity from the undiscounted $168.56 consensus target). The house valuation explicitly discounts forward cash flows using a rigorous 10.99% WACC, accounts for cyclical commodity volatility, and reflects a balanced recovery trajectory rather than peak price extrapolation. The forward earnings model anchors the valuation at $103.76, while the multi-stage moat fade model contributes $156.35, yielding a balanced composite midpoint.1
At the share price of $98.51 as of October 12, 2026, the stock offers an implied return of 9.83% to Fair value, which falls short of the hurdle required to initiate a Buy recommendation. While rapid acceleration in stationary grid storage deployments (consumption up 45% YoY through May 2026) provides strong volume support, near-term profitability remains constrained by a four-month spodumene inventory conversion lag and ongoing Chinese lepidolite and African mine supply expansions. Investors are advised to maintain existing holdings and await a wider margin of safety before expanding position exposure.3
Albemarle's brine operations at Salar de Atacama and 49% stake in Greenbushes via Talison provide a durable bottom-quartile cost position that shields operational cash flow across commodity downcycles.35
A sharp reduction in capital expenditures to $589,801,000 in FY2025 generated $692,466,000 in free cash flow, eliminating cash burn risks without requiring dilutive equity financing.45
Global grid battery storage consumption grew 45% YoY through May 2026, with 2030 stationary storage demand outlook raised to 1,500-2,000 GWh.
The investment committee affirms a Hold rating. Albemarle has successfully navigated the cyclical commodity trough by rationalizing capital expenditures to $589,801,000 and restoring positive free cash flow of $692,466,000 in FY2025. However, at the share price of $98.51 as of October 12, 2026, an implied return of 9.83% to Fair value of $108.19 offers an inadequate margin of safety against a four-month spodumene inventory lag and ongoing Chinese lepidolite and African hard-rock supply expansions.345
Albemarle Corporation is a global specialty chemicals enterprise headquartered in Charlotte, North Carolina, and a leading supplier of battery-grade lithium compounds used in electric vehicles and stationary energy storage systems.
The company operates through three principal business segments: Energy Storage, which produces lithium carbonate, lithium hydroxide, and related compounds from brine operations in Chile (Salar de Atacama) and hard-rock spodumene deposits in Australia (Greenbushes via the Talison joint venture); Specialties, which provides bromine and catalyst derivative solutions for industrial and consumer applications; and Ketjen, which supplies refining catalysts.
In FY2025, consolidated revenue totaled $5,142,733,000, led by Energy Storage with $2,710,035,000 and Specialties with $1,366,435,000. Geographically, China represented $2,026,293,000 (39.4%) of sales, followed by the United States at $890,498,000 (17.3%), South Korea at $789,547,000 (15.4%), and Japan at $359,631,000 (7.0%).
In a severe cyclical stress test, aggressive expansion of low-grade Chinese lepidolite and African hard-rock mines keeps market lithium prices depressed below $15/kg LCE for an extended horizon. Concurrently, downstream battery demand decelerates due to electric vehicle subsidy rollbacks and export VAT revisions. A four-month spodumene inventory lag delays cost deflation, trapping conversion margins near 8% and preventing a return to historical mid-cycle profitability. Under this stress case, fixed financing charges on $1,998,937,984 in total debt with a pre-tax cost of debt of 19.76% constrain liquidity and force severe capital rationing. This compresses equity value toward the downside valuation bound of $49.95.
Albemarle Corporation possesses a narrow economic moat rooted primarily in its structural cost advantages across tier-one lithium extraction deposits. The company holds long-term extraction rights at the Salar de Atacama brine resource in Chile and owns a 49% interest in the Talison Lithium joint venture, which operates the premier Greenbushes hard-rock spodumene mine in Western Australia. Brine evaporation and high-grade hard-rock mining represent the two lowest-cost production methods globally, positioning Albemarle in the bottom quartile of the industry cash cost curve. This cost positioning proved decisive during the FY2025 commodity trough, allowing Albemarle to generate $1,282,267,000 in operating cash flow despite severe cyclical price compression.
Beyond raw resource quality, Albemarle reinforces its competitive positioning through intangible assets and high customer switching costs in downstream refining. Battery-grade lithium carbonate and hydroxide must meet exacting chemical tolerances and strict purity standards required by tier-1 cathode manufacturers and automotive original equipment manufacturers. Qualifying a chemical conversion facility requires 12 to 24 months of extensive product testing and customer audits. These entrenched relationships span critical geographic manufacturing corridors, as demonstrated by FY2025 regional revenues of $2,026,293,000 in China, $890,498,000 in the United States, and $789,547,000 in South Korea.
However, the moat is rated narrow rather than wide due to the high cyclical of upstream commodity markets and the significant capital intensity required to develop conversion capacity. During downcycles, excess supply from swing producers can depress prices below total accounting cost, temporarily driving corporate returns below the cost of capital, as observed in FY2025 with an operating loss of -$367,084,000. Furthermore, operational execution risks, four-month spodumene inventory conversion lags, and evolving concession frameworks in Chile introduce medium-term headwinds that constrain moat durability to a narrow horizon.
The highlighted cell is Fair value when every assumption sits at its base level ($108.19). Each row and column shows what Fair value becomes when one assumption moves.
Free cash flow to the firm stays positive in the first projected year at $423.2M after modeled reinvestment of $181.4M, with terminal value at 68.1% of enterprise value. A sudden drop in free cash flow is not projected unless capital spending relative to , reinvestment, or resets materially.
A sustained beat demonstrates that unit margin recovery is accelerating ahead of the scheduled normalization path, driven by immediate spodumene cost deflation and surging grid storage off-take, warranting an upgrade in stance.
Albemarle reduced capital expenditures from peak expansion spending to $589,801,000 in FY2025, falling below annual depreciation and amortization of $658,678,000. Across the broader specialty chemicals peer group, the industry capex-to-revenue ratio sits at 4.1% and capex-to-depreciation is 1.55.5
The lithium industry upcycle is underpinned by multi-gigawatt-hour acceleration in stationary grid energy storage, where lithium consumption increased 45% year-over-year through May 2026. Albemarle raised the low end of its 2030 stationary storage demand forecast by 9% to 1,500-2,000 GWh, expanding total 2030 lithium demand expectations by 100,000 tons. In China, battery installation rates have exceeded cell manufacturing output, creating commercial tightness in iron phosphate chemistries. As electric vehicle sales trend higher and market lithium prices consolidate above $20/kg LCE, producers with qualified downstream refining assets stand to capture strong operating leverage.
The lithium downcycle reflects massive upstream capacity additions from Chinese lepidolite mining and newly developed African hard-rock spodumene projects. This rapid supply expansion drove Albemarle's consolidated down from $9,617,203,000 in FY2023 to $5,142,733,000 in FY2025, generating a consolidated operating loss of -$367,084,000. Full-year 2026 Energy Storage volumes are guided flat to down 4%, while EV subsidy rollbacks and battery VAT export policy changes continue to create demand .
A moderate conviction weighting of 2-3% balances Albemarle's tier-one resource advantage and positive free cash flow inflection against cyclical spot lithium volatility, four-month inventory lag risks, and a hold rating offering 9.83% upside to Fair value of $108.19.
Cap total portfolio exposure at 3% to limit cyclical downside risk. Actively track quarterly lithium carbonate spot benchmarks, monitor Talison joint venture cash distributions, and evaluate total debt obligations of $1,998,937,984 against trailing EBITDA coverage.
Albemarle's low-cost resource base at Salar de Atacama and Greenbushes provides robust downside asset protection, and free cash flow turned positive at $692,466,000 in FY2025. However, at $98.51 as of October 12, 2026, an implied return of 9.83% to Fair value of $108.19 provides an insufficient margin of safety to justify a Buy rating.24
Stationary grid storage lithium consumption grew 45% YoY through May 2026, offering multi-year volume expansion. Nevertheless, near-term volume guidance of flat to down 4% in FY2026 and pricing consolidation near $20/kg LCE suggest top-line acceleration is already appropriately reflected in current valuations.3
Albemarle is assigned a Hold rating with a Fair value of $108.19, representing 9.83% upside from the share price of $98.51 as of October 12, 2026.2
While tier-one resource assets and sharp capital expenditure reductions have successfully restored positive free cash flow generation, near-term upside is capped by a four-month spodumene inventory lag and ongoing refined supply expansion from competing lepidolite and hard-rock producers.
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
The records this analysis drew on, as they stood when it was run.
In the Bear scenario, persistent supply growth from African hard-rock and Chinese lepidolite mining maintains global market oversupply, keeping spot lithium carbonate pricing depressed near trough levels. Downstream battery demand decelerates amid policy shifts and subsidy rollbacks in major automotive markets, leaving conversion facilities underutilized. Unit margins remain constrained near single digits as four-month inventory lags exacerbate feedstock cost friction, while corporate cash generation is further weighed down by fixed debt service obligations and royalty payments. Under these adverse conditions, capital expenditures face mandatory retrenchment to preserve balance sheet liquidity.
Rapid expansion of African hard-rock spodumene and Chinese lepidolite mining holds spot lithium prices near trough levels, preventing margin recovery from FY2025 (-7.14%) and depressing normalized EBIT margins 6 percentage points below the 14.0% base case target.35
Energy Storage volume guided flat to down 4% in 2026 and consolidated revenue down from $9,617,203,000 in FY2023 to $5,142,733,000 in FY2025. Rollback of EV incentives and battery VAT export changes shock 5-year annual revenue growth by 10 percentage points below baseline.35
Total debt of $1,998,937,984, strained cash conversion and margin durability, and negative trough earnings compress the mid-cycle exit multiple by 20% from 12.0x toward chemical peer multiples.2
The five developments that would weaken our investment case.
Indicates rapid lepidolite and African hard-rock expansion outpacing demand, suppressing EBIT margin normalization below the 14.0% base expectation and prolonging operating losses.
Current:~$20/kg LCE in H1 2026
Alert ifBelow $12/kg LCE for two consecutive quarters
Breaches bottom-quartile cost curve protection, indicating inventory lag headwinds or high royalties are overwhelming cash generation and invalidating the structural cost advantage thesis.
Current:$1,282,267,000 in FY2025
Alert ifAt or below $0 in FY2026
Signifies accelerated market share loss or battery installation slowdown, invalidating long-term volume off-take assumptions and forcing downward revisions to medium-term revenue forecasts.
Current:Guided flat to down 4% in FY2026
Alert ifBelow -5% YoY in FY2026
Loss of bromine pricing power or escalating input costs would erode the non-lithium earnings anchor, increasing corporate vulnerability to upstream lithium volatility.
Current:Guided FY2026 segment net sales of $1.4B-$1.6B and EBITDA of $275M-$325M (~18-20% EBITDA margin)
Alert ifOperating margin below 10% in FY2026
Extended downtime across conversion plants drives unit conversion costs higher, delays customer volume deliveries, and impairs near-term EBITDA generation.
Current:Restarting operations with inventory buffer at ~19% of sales following CGP3 fire
Alert ifExceeding 90 days reducing annual production by over 10%
Economic profit generation for Albemarle is highly cyclical. During market peaks, structural low-cost extraction drives returns on invested capital substantially above the cost of capital. In cyclically depressed periods such as FY2025, operating losses of -$367,084,000 and net losses of -$510,628,000 temporarily pull ROIC well below the computed 10.99% WACC. However, because Albemarle's Salar de Atacama brine operations and 49% stake in Greenbushes via Talison occupy the bottom quartile of global cost curves, positive operating cash flow of $1,282,267,000 was maintained in FY2025. As spot prices consolidate above $20/kg LCE and normalized EBIT margins reach 14.0%, economic value added is projected to turn sustainably positive.135
Each lens answers a different valuation question. Only included lenses set Fair value; floors and diagnostics provide context.
Project EPS through the explicit advantage period, fade growth as competition catches up, and discount the full stream at cost of equity.
Apply a terminal P/E to the dated forward EPS path, then discount that future share value back to the analysis date.
Convert the revenue and margin path into after-tax free cash flow, discount the annual per-share amounts and at , then adjust for signed per current share.
Solve for the growth rate that makes the model value equal the report-date share price.
In the Base scenario, Albemarle delivers on its operational recovery as global lithium supply and demand rebalance at normalized mid-cycle levels. Energy storage demand continues expanding across grid installations, while downstream electric vehicle manufacturing absorbs refined lithium compounds. The company's tier-one brine assets at Salar de Atacama and hard-rock operations at Greenbushes generate resilient operational cash flows, and unit conversion margins expand as spodumene inventory lag effects diminish. Specialties delivers steady revenue and margin performance, cushioning corporate profitability. Under these conditions, the shares reflect the house Fair value target of $108.19, representing 9.8% return from $98.51 with a 55.0% probability weighting.
In the Bull scenario, aggressive expansion in utility-scale stationary storage installations combines with an accelerated rebound in electric vehicle adoption to tighten refined lithium markets ahead of schedule. Spot lithium carbonate pricing strengthens above mid-cycle assumptions, and customer contract realizations exceed expectations. Albemarle's low-capital brownfield expansion projects come online efficiently, driving volume expansion across qualified conversion assets in the United States and Asia. Concurrently, Specialties capitalizes on robust bromine pricing and cost productivity gains, lifting operating profitability toward specialty chemical peer benchmarks. Under this upside trajectory, the shares achieve Potential value of $162.13, yielding 64.6% return against $98.51 with a 20.0% probability weighting.
Inline performance confirms that Albemarle is progressing along its multi-year margin recovery trajectory, validating the house Fair value of $108.19 and 9.8% upside relative to $98.51.
A substantial earnings miss caused by renewed supply flooding from African hard-rock or Chinese lepidolite operations would indicate prolonged margin compression below mid-cycle assumptions, threatening debt service capacity and forcing fair value revisions.
Earnings quality reflects a cyclical trough inflection. Operating cash flow proved resilient at the commodity bottom, comfortably exceeding capital expenditures as large-scale greenfield construction concluded. Working capital requirements have begun stabilizing, though a four-month spodumene inventory lag temporarily delays the recognition of lower input costs. Cash conversion is supported by steady specialty chemical contributions and Talison joint venture distributions, while core operating expenses remain disciplined.
Consensus earnings estimates have seen modest downward revisions following management's conservative volume guidance and ongoing absorption of the four-month spodumene inventory lag. However, revisions have begun flattening as Specialties earnings guidance remains firm and stationary grid storage demand provides volume support across Asian conversion channels.
Pricing realization directly dictates top-line revenue expansion and operating margin leverage across Energy Storage conversion assets.
A four-month inventory processing lag delays raw material cost deflation, determining the exact timing of gross margin inflection.
Volume off-take reveals customer demand momentum across automotive and stationary grid storage installations, anchoring capacity utilization.
Differentiated bromine and catalyst cash flows provide essential through-cycle stability, dampening corporate exposure to upstream lithium volatility.
Positive operating cash generation covering reduced capital outlays validates free cash flow self-sufficiency and balance sheet protection.
| $3.33B |
| $7.32B |
| $9.62B |
| $5.38B |
| $5.14B |
| +11.5% |
| Gross profit | $998.0M | $3.07B | $1.19B | $62.5M | $668.7M | -9.5% |
| Operating income | $798.4M | $2.47B | $251.9M | $-1.78B | $-367.1M | — |
| Net income | $123.7M | $2.69B | $1.57B | $-1.18B | $-510.6M | — |
| EPS (diluted) | $1.06 | $22.84 | $13.36 | $-11.20 | $-5.76 | — |
| EBITDA | $544.9M | $3.63B | $2.65B | $-294.1M | $558.0M | +0.6% |
| R&D | $54.0M | $72.0M | $85.7M | $86.7M | $51.4M | -1.2% |
| SG&A | $441.5M | $524.1M | $910.0M | $618.0M | $550.0M | +5.7% |
Albemarle's cash flow profile has achieved a pivotal turnaround. Despite a severe commodity pricing trough that produced a GAAP net loss of -$510,628,000 in FY2025, operating cash flow remained robust at $1,282,267,000. This divergence underscores the non-cash nature of cyclical accounting impairments and the resilience of underlying cash extraction margins. By curtailing capital outlays from peak greenfield levels to $589,801,000, Albemarle generated $692,466,000 in positive free cash flow. Working capital needs are normalizing as spodumene inventory moves through its four-month processing cycle, setting the foundation for sustained multi-year cash conversion.345
Management has enforced disciplined capital allocation following multi-year expansion programs. Capital expenditures are strictly prioritized for high-return brownfield projects such as Salar de Atacama debottlenecking, Kings Mountain, and Antofalla, while uncommitted greenfield outlays remain paused. With total debt of $1,998,937,984 and a 14.67% debt weight, preserving balance sheet strength is the paramount objective. The forecast models a steady reinvestment rate of 30.0% of NOPAT, balancing essential sustaining capital with debt de-leveraging and baseline dividend payments.
ROIC is rebounding from cyclical trough levels where FY2025 operating losses of -$367,084,000 produced negative returns on capital. As operating income normalizes toward projected EBIT of $765,367,238.72 in FY2026 (12.5% operating margin) and $819,224,600.58 in FY2027 (13.0% operating margin), return on invested capital expands steadily toward mid-cycle levels.
At the FY2025 commodity trough, ROIC sat deep below the computed 10.99% WACC. Over the explicit forecast horizon, projected EBIT growth and a steady 30.0% reinvestment rate are modeled to drive through-cycle ROIC above WACC, re-establishing economic profit generation.
Capital expenditures declined to $589,801,000 in FY2025 while operating cash flow held at $1,282,267,000, producing $692,466,000 in positive free cash flow.
The sharp reduction in capital intensity converts Albemarle from a heavy cash burner into a self-funding business, shielding liquidity and supporting debt service during commodity downcycles.
Specialties generated $1,366,435,000 in FY2025 revenue, with management guiding FY2026 segment sales to $1.4B-$1.6B and EBITDA to $275M-$325M.
The non-lithium bromine and catalyst franchise provides predictable operating earnings that dampen upstream commodity earnings volatility and support consolidated debt coverage.
Management disclosed a four-month inventory flow-through lag for spodumene, where Q2 average feedstock costs of $2,500/ton lagged declining spot prices near $2,000/ton.
Conversion margins will experience sequential expansion in H2 2026 and FY2027 as high-cost inventory washes through the system and is replaced by lower-cost raw materials.
| Revenue | $1,743,313,000 |
|---|---|
| Cost of revenue | $1,153,012,000 |
| Gross profit | $590,301,000 |
| Operating expenses | $137,357,000 |
| Operating income | $452,944,000 |
| Non-operating items and tax | $46,267,000 |
| Net income | $499,211,000 |
| Total assets | $16,374,211,000 |
|---|---|
| Cash | $1,618,001,000 |
| Current assets | $4,008,139,000 |
| Total liabilities | $6,592,750,000 |
| Current liabilities | $1,798,044,000 |
| Shareholders’ equity | $9,781,461,000 |
| Net income | $1,573,476,000 |
|---|---|
| Operating inflow | $2,039,965,000 |
| Depreciation and amortization | $429,944,000 |
| Stock-based compensation | $36,545,000 |
| Operating cash flow | $1,326,583,000 |
| Operating outflow | $713,382,000 |
| Cash available | $3,454,472,000 |
| Beginning cash | $1,499,142,000 |
| Financing inflow | $623,911,000 |
| Exchange-rate effect | $4,836,000 |
| Investing outflow | $2,564,572,000 |
| Capex | $2,154,542,000 |
| Other investing activities | $410,030,000 |
| Ending cash | $889,900,000 |
| Investing cash flow | -$2,564,572,000 |
| Financing cash flow | $623,911,000 |
Source: SEC EDGAR · Filed 2026-02-11 · SEC EDGAR
| Revenue by operating segment | Revenue | Share | YoY |
|---|---|---|---|
| Energy Storage | $2.7B | 52.7% | -10.1% |
| Specialties | $1.4B | 26.6% | 3.1% |
| Ketjen | $1.1B | 20.7% | 2.9% |
Source: SEC EDGAR · Filed 2026-02-11 · SEC EDGAR
| Revenue by geography | Revenue | Share | YoY |
|---|---|---|---|
| China | $2B | 39.4% | 3.3% |
| Other Foreign | $1.1B | 20.9% | 6.3% |
| United States | $890.5M | 17.3% | -1.3% |
| South Korea | $789.5M | 15.4% | -13.5% |
| Japan | $359.6M | 7% | -39% |
Point-in-time financial data used in the 2026-10-12 analysis.
| Period | Revenue | EBITDA | Net income | Operating cash flow | Free cash flow | Capex | Depreciation and amortization | Stock-based compensation | Share repurchases | Dividends paid | Net debt issuance | Investing cash flow | Financing cash flow | Beginning cash | Ending cash | Cash and investments | Total debt | Operating margin | ROIC | WACC | ROIC − WACC spread |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $2.7B | $735.8M | $643.7M | $735.5M | $538.9M | $196.7M | $226.2M | $17M | $0 | $135.4M | — | $2.9B | -$1.6B | — | $2.3B | $2.3B | $2.4B | 22.4% | — | 6.5% | — |
| 2017-12-31 | $3.1B | $819.5M | $54.9M | $304M | -$13.7M | $317.7M | $196.9M | $19.4M | $250M | $140.6M | — | -$357.8M | -$1.1B | $2.3B | $1.1B | $1.1B | $1.8B | 18.6% | — | 6.7% | — |
| 2018-12-31 | $3.4B | $925M | $693.6M | $546.2M | -$153.8M | $700M | $200.7M | $15.2M | $500M | $144.6M | — | -$303.7M | -$786.5M | $1.1B | $555.3M | $555.3M | $1.7B | 27.0% | — | 6.9% | — |
| 2019-12-31 | $3.6B | $898.8M | $533.2M | $719.4M | -$132.4M | $851.8M | $213.5M | $19.7M | $0 | $152.2M | — | -$1.7B | $1B | $555.3M | $613.1M | $613.1M | $3.1B | 18.6% | — | 5.7% | — |
| 2020-12-31 | $3.1B | $757.7M | $375.8M | $798.9M | -$51.6M | $850.5M | $232M | $22.8M | $0 | $161.8M | — | -$863.6M | $177.3M | $613.1M | $746.7M | $1.4B | $3.6B | 16.2% | — | 5.6% | — |
| 2021-12-31 | $3.3B | $544.9M | $123.7M | $344.3M | -$609.4M | $953.7M | $254M | $20.1M | — | $177.9M | — | -$666.6M | $50.2M | $746.7M | $439.3M | $1.3B | $2.4B | 24.0% | — | 6.7% | — |
| 2022-12-31 | $7.3B | $3.6B | $2.7B | $1.9B | $646.2M | $1.3B | $300.8M | $30.5M | — | $184.4M | $867.6M | -$1.4B | $611.9M | $439.3M | $1.5B | $1.5B | $3.2B | 33.7% | — | 8.8% | — |
| 2023-12-31 | $9.6B | $2.6B | $1.6B | $1.3B | -$828M | $2.2B | $429.9M | $36.5M | — | $187.2M | $944.2M | -$2.6B | $623.9M | $1.5B | $889.9M | $889.9M | $4.2B | 2.6% | — | 8.9% | — |
| 2024-12-31 | $5.4B | -$294.1M | -$1.2B | $687.9M | -$992.7M | $1.7B | $588.6M | $32.1M | — | $188.5M | -$631.8M | -$1.6B | $1.2B | $889.9M | $1.2B | $1.2B | $3.5B | -33.0% | — | — | — |
| 2025-12-31 | $5.1B | $558M | -$510.6M | $1.3B | $692.5M | $589.8M | $658.7M | $40.3M | — | $190.5M | -$454.7M | -$146M | -$834.2M | $1.2B | $1.6B | $1.6B | $3.2B | -7.1% | — | — | — |
Albemarle Corporation (ALB) trades at 11.4x forward earnings against a peer median of 18.8x. Its EV/EBITDA of 9.8x compares with a peer median of 13.2x. The comparison uses 4 peers: DuPont de Nemours Inc., International Flavors & Fragrances Inc., PPG Industries Inc. and The Sherwin-Williams Company, as of 2026-10-11 to 2026-10-12.
Albemarle occupies a defensively positioned, low-cost advantage in the lithium supply curve through its Salar de Atacama brine operations and 49% stake in Greenbushes. Having completed major greenfield capital spending and brought capex below D&A, the company has successfully pivoted to positive free cash flow generation while retaining substantial operational leverage to an eventual demand-led market tightening.
| Why |
|---|
| $85.00 - $90.00 | Accumulate initial tranche | Trading near the 52-week low of $88.01 widens the margin of safety to 18.65% relative to the Fair value of $108.19. |
| $95.00 - $98.51 | Hold existing allocation | The share price of $98.51 as of October 12, 2026 offers a 9.83% implied return to Fair value of $108.19, warranting patient observation rather than aggressive sizing. |
The modest dividend of $1.64 per share is backed by $1,282,267,000 in operating cash flow, but total debt of $1,998,937,984 and cyclical commodity exposure make the security unsuitable for income-seeking or capital-preservation mandates.25
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
Discounted forecast-period cash flows ($15.07) plus discounted terminal value ($32.15) minus signed net debt per current share ($13.35) equals the $33.87 lens value shown above. Negative net debt is net cash, so subtracting it raises value.
Project revenue, apply a terminal EV/revenue multiple, discount enterprise value, subtract net debt, and divide by diluted shares.
| International Flavors & Fragrances Inc. |
| $21.7B |
| 21.4x |
| 2.0x |
| 14.3x |
| -5.5% |
| 8.5% |
| PPG | PPG Industries Inc. | $23.1B | 12.0x | 1.4x | 10.8x | 19.3% | 14.0% |
| SHW | The Sherwin-Williams Company | $77.5B | 23.6x | 3.2x | 19.6x | 65.1% | 18.1% |
